Subscribe for relevant insights delivered straight to your inbox
We see reason to remain optimistic in 2020 by focusing on companies whose business models support a sustainable global economy.
Nick Maroutsos explains why the Fed’s refusal to address structural flaws in short-term lending markets risks a repeat of September’s repo market volatility.
After a volatile 2019, what can health care investors expect in the new year?
As equity multiples climb, we believe investors should focus on high-quality value or cyclical stocks to help minimize risk.
Signs of a slight uptick in global economic growth next year are emerging. Should the growth materialize, we think stocks could benefit.
There’s more than one way to gain exposure to advances in oncology, say Andy Acker, Dan Lyons and Luyi Guo of the Global Life Sciences Team.
